Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Compass Therapeutics (CMPX) Current Leases: 2023-2024

Historic Current Leases for Compass Therapeutics (CMPX) over the last 2 years, with Dec 2024 value amounting to $338,000.

  • Compass Therapeutics' Current Leases rose 13.64% to $633,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $633,000, marking a year-over-year increase of 13.64%. This contributed to the annual value of $338,000 for FY2024, which is 71.76% down from last year.
  • Per Compass Therapeutics' latest filing, its Current Leases stood at $338,000 for FY2024, which was down 71.76% from $1.2 million recorded in FY2023.
  • Compass Therapeutics' 5-year Current Leases high stood at $1.2 million for FY2023, and its period low was $338,000 during FY2024.
  • Over the past 2 years, Compass Therapeutics' median Current Leases value was $767,500 (recorded in 2023), while the average stood at $767,500.
  • Data for Compass Therapeutics' Current Leases shows a maximum YoY crashed of 71.76% (in 2024) over the last 5 years.
  • Over the past 2 years, Compass Therapeutics' Current Leases (Yearly) stood at $1.2 million in 2023, then slumped by 71.76% to $338,000 in 2024.